Gallebo, Mayco P.

HRN: 27-13-61  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/18/2025
CLINDAMYCIN 150MG/ML, 4ML (AMP)
05/19/2025
05/26/2025
IV
300mg
1hr PTOR, Then Q8hrs
Empiric
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Bone & JointEye, Ear, Nose, Throat, & Mouth    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: